SCHEMBL1665713

SCHEMBL1665713

Cc1ccc(S(=O)(=O)Oc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
ENPP2 Q13822 4/20 0.59
ENPP1 P22413 4/20 0.59
EGFR P00533 3/20 0.59
ENPP3 O14638 3/20 0.59
ABL1 P00519 2/20 0.59
ABL2 P42684 1/20 0.58
GFER P55789 1/20 0.57
PPARG P37231 1/20 0.57
ALDH1A1 P00352 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
STAT3 P40763 1/20 0.56
GAA P10253 2/20 0.55
MAPT P10636 2/20 0.55
G6PD P11413 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
LMNA P02545 1/20 0.53
SRD5A2 P31213 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8496744 0.91 KMT2A (0.76) MEN1KMT2AENPP2ENPP1EGFR
Hydrochloric Acid SCHEMBL7053221 0.90 KMT2A (0.73) MEN1KMT2AENPP2ENPP1EGFR
SCHEMBL4325565 0.87 KMT2A (0.70) MEN1KMT2AENPP2ENPP1ENPP3
SCHEMBL30899144 0.86 MEN1 (0.64) MEN1KMT2AENPP2ENPP1EGFR
SCHEMBL27472523 0.86 ALDH1A1 (0.59) MEN1KMT2AENPP2ENPP1ENPP3
SCHEMBL4126086 0.86 MEN1 (0.60) MEN1KMT2AENPP2ENPP1ENPP3
SCHEMBL18179825 0.86 MEN1 (0.60) MEN1KMT2AENPP2ENPP1ENPP3
SCHEMBL9852204 0.86 MEN1 (0.60) MEN1KMT2AENPP2ENPP1ENPP3
SCHEMBL1665319 0.85 ENPP1 (0.61) MEN1KMT2AENPP2ENPP1ENPP3
SCHEMBL16182665 0.85 MEN1 (0.68) MEN1KMT2AENPP1EGFRENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119191978-A Method for synthesizing meta-secondary alkyl substituted aryl carboxylic acid 华南理工大学 2024-12-27 CN disclosed
US-11774853-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-03 US disclosed
CN-111018691-B Green synthesis method of aromatic acid 中国科学技术大学 2022-03-01 CN disclosed
US-11187980-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-11-30 US disclosed
US-20210302838-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-09-30 US disclosed
US-20200241414-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-07-30 US disclosed
US-20200192222-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-06-18 US disclosed
CN-111018691-A Green synthesis method of aromatic acid 中国科学技术大学 2020-04-17 CN disclosed
US-20200073237-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-03-05 US disclosed
US-10474030-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-11-12 US disclosed
US-9360753-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-07 US disclosed
US-9164383-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-10-20 US disclosed
US-20130029270-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-01-31 US disclosed
US-20120202153-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-09 US disclosed
US-20120202153-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-09 US disclosed
EP-2314581-B1 A process for preparing benzo[b]thiophene derivatives HEXAL AG (DE) 2012-07-25 EP disclosed
WO-2011047877-A1 A PROCESS FOR PREPARING BENZO[B]THIOPHENE DERIVATIVES HEXAL AKTIENGESELLSCHAFT (DE) 2011-04-28 WO disclosed
EP-2314581-A1 A process for preparing benzo[b]thiophene derivatives Hexal AG (DE) 2011-04-27 EP disclosed
US-4520026-A ANTIARRHYTHMIA AGENTS S. A. LABAZ N.V. (BE) 1985-05-28 US disclosed
US-4378362-A CARDIOVASCULAR DISORDERS S.A. LABAZ N.V. (BE) 1983-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200241414-A1 RESIST COMPOSITION AND PATTERNING PROCESS INSR, HNRNPU, HNRNPR MEN1 2251/4885KMT2A 1882/4885ENPP2 4352/4885
US-10474030-B2 Resist composition and patterning process CASR, HNRNPU, LBR MEN1 3269/4885KMT2A 2749/4885ENPP2 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.